- A small randomised trial and observation of all patients homozygous for beta-thalassaemia in Britain born in or before 1963 indicated that those patients who had received average weekly doses of more than 4 g of desferrioxamine over the previous few years were less likely to die in the near future than were patients of similar ages who had received less, or no, desferrioxamine.
- Publication status:
- British medical journal (Clinical research ed.)
- Publication date:
- Source identifiers:
- Local pid:
- Copyright date:
Survival and desferrioxamine in thalassaemia major.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record